Application Information

This drug has been submitted to the FDA under the reference 205422/001.

Names and composition

"REXULTI" is the commercial name of a drug composed of BREXPIPRAZOLE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
205422/001 REXULTI BREXPIPRAZOLE TABLET/ORAL 0.25MG
205422/002 REXULTI BREXPIPRAZOLE TABLET/ORAL 0.5MG
205422/003 REXULTI BREXPIPRAZOLE TABLET/ORAL 1MG
205422/004 REXULTI BREXPIPRAZOLE TABLET/ORAL 2MG
205422/005 REXULTI BREXPIPRAZOLE TABLET/ORAL 3MG
205422/006 REXULTI BREXPIPRAZOLE TABLET/ORAL 4MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
205422/001 REXULTI BREXPIPRAZOLE TABLET/ORAL 0.25MG
205422/002 REXULTI BREXPIPRAZOLE TABLET/ORAL 0.5MG
205422/003 REXULTI BREXPIPRAZOLE TABLET/ORAL 1MG
205422/004 REXULTI BREXPIPRAZOLE TABLET/ORAL 2MG
205422/005 REXULTI BREXPIPRAZOLE TABLET/ORAL 3MG
205422/006 REXULTI BREXPIPRAZOLE TABLET/ORAL 4MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved